Correlation Between Royal Bank and Helix BioPharma

Can any of the company-specific risk be diversified away by investing in both Royal Bank and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Bank and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Royal Bank of and Helix BioPharma Corp, you can compare the effects of market volatilities on Royal Bank and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Bank with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Bank and Helix BioPharma.

Diversification Opportunities for Royal Bank and Helix BioPharma

0.46

Correlation Coefficient

Royal Bank  Helix BioPharma

Very weak diversification

The 3 months correlation between Royal and Helix is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Royal Bank of and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and Royal Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Bank of are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of Royal Bank i.e., Royal Bank and Helix BioPharma go up and down completely randomly.

Pair Corralation between Royal Bank and Helix BioPharma

Assuming the 90 days horizon Royal Bank of is expected to generate 0.23 times more return on investment than Helix BioPharma. However, Royal Bank of is 4.27 times less risky than Helix BioPharma. It trades about -0.04 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about -0.03 per unit of risk. If you would invest  17,289  in Royal Bank of on December 26, 2024 and sell it today you would lose (624.00) from holding Royal Bank of or give up 3.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Royal Bank of  vs.  Helix BioPharma Corp

Royal Bank

Risk-Adjusted Performance

Very Weak

Over the last 90 days Royal Bank of has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Royal Bank is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Helix BioPharma Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Royal Bank and Helix BioPharma

The main advantage of trading using opposite Royal Bank and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Bank position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.

The idea behind Royal Bank of and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.